Literature DB >> 19112609

Trimethyl chitosan and its applications in drug delivery.

V K Mourya1, Nazma N Inamdar.   

Abstract

Chitosan, a polymer obtained by deacetylation of chitin is widely studied for its pharmaceutical and nonpharmaceutical applications. Recommendations about uses of this polymer although could not be always realized due to limited solubility. Chitosan, for example, has been extensively evaluated for its mucoadhesive and absorption enhancement properties. The positive charge on the chitosan molecule gained by acidic environment in which it is soluble seems to be important for absorption enhancement. However chitosan is not soluble in medium except below pH 5.6. This limits its use as permeation enhancer in body compartments where pH is high. In this regard there is a need for chitosan derivatives with increased solubility, especially at neutral and basic pH values. Trimethylation of chitosan is an effort in this direction. Despite the abundance of the research related to trimethyl chitosan (TMC), the overview of the topic is not available. Hence an attempt is made in this review to cover the recent findings pertaining to synthesis, characterization and applications of TMC especially in pharmaceutical field. TMC has been synthesized by different ways and characterized by FTIR, NMR, DSC etc. This quaternized derivative of chitosan possesses a positive charge and is soluble over a wide range of pH. TMC, being a derivative of cationic polymer enriched with positive charge shows better mucoadhesive, permeation enhancement, drug delivery and DNA delivery properties. TMC can be further derivitized or grafted for modulating properties as solubility, cytotoxicity or cell recognition ability. Apart from these applications, TMC itself and its derivatives exhibit antimicrobial properties also. Quaternization of chitosan not only with methyl group but higher group as ethyl or along with spacer or quaternization of modified chitosan can be of interest too.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19112609     DOI: 10.1007/s10856-008-3659-z

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  89 in total

1.  Chitosans as absorption enhancers for poorly absorbable drugs. 1: Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells.

Authors:  N G Schipper; K M Vårum; P Artursson
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

2.  Intestinal absorption of octreotide using trimethyl chitosan chloride: studies in pigs.

Authors:  M Thanou; J C Verhoef; J H Verheijden; H E Junginger
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

3.  Uptake and transport of PEG-graft-trimethyl-chitosan copolymer-insulin nanocomplexes by epithelial cells.

Authors:  Shirui Mao; Oliver Germershaus; Dagmar Fischer; Thomas Linn; Robert Schnepf; Thomas Kissel
Journal:  Pharm Res       Date:  2005-09-26       Impact factor: 4.200

4.  Surface fabrication of hollow microspheres from N-methylated chitosan cross-linked with glutaraldehyde.

Authors:  Xianghong Peng; Lina Zhang
Journal:  Langmuir       Date:  2005-02-01       Impact factor: 3.882

5.  Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models.

Authors:  Giuseppina Sandri; Maria Cristina Bonferoni; Silvia Rossi; Franca Ferrari; Sara Gibin; Ylenia Zambito; Giacomo Di Colo; Carla Caramella
Journal:  Eur J Pharm Biopharm       Date:  2006-07-27       Impact factor: 5.571

6.  Efficacy of pulmonary insulin delivery in diabetic rats: use of a model-based approach in the evaluation of insulin powder formulations.

Authors:  Maryam Amidi; Kevin M Krudys; Cor J Snel; Daan J A Crommelin; Oscar E Della Pasqua; Wim E Hennink; Wim Jiskoot
Journal:  J Control Release       Date:  2008-02-12       Impact factor: 9.776

7.  New bioactive biomaterials based on quaternized chitosan.

Authors:  Rachid Belalia; Stéphane Grelier; Mohammed Benaissa; Véronique Coma
Journal:  J Agric Food Chem       Date:  2008-02-14       Impact factor: 5.279

8.  Methylated N-(4-N,N-dimethylaminobenzyl) chitosan for novel effective gene carriers.

Authors:  Theerasak Rojanarata; Maleenart Petchsangsai; Praneet Opanasopit; Tanasait Ngawhirunpat; Uracha Ruktanonchai; Warayuth Sajomsang; Supawan Tantayanon
Journal:  Eur J Pharm Biopharm       Date:  2008-05-01       Impact factor: 5.571

9.  In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis.

Authors:  Dagmar Fischer; Youxin Li; Barbara Ahlemeyer; Josef Krieglstein; Thomas Kissel
Journal:  Biomaterials       Date:  2003-03       Impact factor: 12.479

10.  Protective immune responses to meningococcal C conjugate vaccine after intranasal immunization of mice with the LTK63 mutant plus chitosan or trimethyl chitosan chloride as novel delivery platform.

Authors:  Barbara C Baudner; J Coos Verhoef; Marzia M Giuliani; Samuele Peppoloni; Rino Rappuoli; Giuseppe Del Giudice; Hans E Junginger
Journal:  J Drug Target       Date:  2005 Sep-Nov       Impact factor: 5.121

View more
  43 in total

Review 1.  Polymeric carriers for gene delivery: chitosan and poly(amidoamine) dendrimers.

Authors:  Qingxing Xu; Chi-Hwa Wang; Daniel Wayne Pack
Journal:  Curr Pharm Des       Date:  2010-07       Impact factor: 3.116

Review 2.  Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.

Authors:  Anumita Chaudhury; Surajit Das
Journal:  AAPS PharmSciTech       Date:  2010-12-11       Impact factor: 3.246

Review 3.  Cell-laden hydrogels for osteochondral and cartilage tissue engineering.

Authors:  Jingzhou Yang; Yu Shrike Zhang; Kan Yue; Ali Khademhosseini
Journal:  Acta Biomater       Date:  2017-01-11       Impact factor: 8.947

4.  Enteric trimethyl chitosan nanoparticles containing hepatitis B surface antigen for oral delivery.

Authors:  Asma Farhadian; Naser Mohammadpour Dounighi; Mohammadreza Avadi
Journal:  Hum Vaccin Immunother       Date:  2015-07-09       Impact factor: 3.452

5.  A fibrin gel loaded with chitosan nanoparticles for local delivery of rhEGF: preparation and in vitro release studies.

Authors:  Wenjun Zhou; Min Zhao; Yuan Zhao; Yan Mou
Journal:  J Mater Sci Mater Med       Date:  2011-03-29       Impact factor: 3.896

Review 6.  A review of solute encapsulating nanoparticles used as delivery systems with emphasis on branched amphipathic peptide capsules.

Authors:  Sheila M Barros; Susan K Whitaker; Pinakin Sukthankar; L Adriana Avila; Sushanth Gudlur; Matt Warner; Eduardo I C Beltrão; John M Tomich
Journal:  Arch Biochem Biophys       Date:  2016-02-27       Impact factor: 4.013

7.  Methylglycol chitosan and a synthetic TLR4 agonist enhance immune responses to influenza vaccine administered sublingually.

Authors:  Justin L Spinner; Hardeep S Oberoi; Yvonne M Yorgensen; Danielle S Poirier; David J Burkhart; Martin Plante; Jay T Evans
Journal:  Vaccine       Date:  2015-09-21       Impact factor: 3.641

8.  Characterization of nanoparticle delivery in microcirculation using a microfluidic device.

Authors:  Antony Thomas; Jifu Tan; Yaling Liu
Journal:  Microvasc Res       Date:  2014-04-29       Impact factor: 3.514

9.  Self-assembled particles of N-phthaloylchitosan-g-polycaprolactone molecular bottle brushes as carriers for controlled release of indometacin.

Authors:  Youju Huang; Liangbin Li; Yue'e Fang
Journal:  J Mater Sci Mater Med       Date:  2009-09-26       Impact factor: 3.896

10.  3-D culture of human umbilical vein endothelial cells with reversible thermosensitive hydroxybutyl chitosan hydrogel.

Authors:  Ya Nan Wei; Qian Qian Wang; Ting Ting Gao; Ming Kong; Kui Kun Yang; Yi An; Shao Yan Jiang; Jian Li; Xiao Jie Cheng; Xi Guang Chen
Journal:  J Mater Sci Mater Med       Date:  2013-03-24       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.